Investment
Features
FeesSafety
Academy
More
Pluang+

Compare DexCom, Inc. (DXCM) vs Schwab US Dividend Equity ETF (SCHD) Price & Performance

DexCom, Inc.Trade
Schwab US Dividend Equity ETFTrade

Price performance (Past 24H)

Key statistics

DexCom, Inc. vs Schwab US Dividend Equity ETF — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while Schwab US Dividend Equity ETF trades at $34.23. Which is the better fit depends on your goals.

DXCMSCHD
Market Cap
$33.79B
Sector
HealthBroad Market / Factor
52-Week High
$89.53$34.27
52-Week Low
$54.84$26.44
Enterprise Value
$33.24B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About DexCom, Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.

Read more on DXCM

About Schwab US Dividend Equity ETF

SCHD is an ETF that tracks the Dow Jones U.S. Dividend 100 Index. It selects high-quality companies with a consistent track record of paying dividends, focusing on financial strength metrics like cash flow to total debt and return on equity, and excluding REITs. The fund aims to provide both income and capital appreciation, making it a popular choice for long-term, dividend-focused investors.

Read more on SCHD